- ISIN
- US92189F6925
- CUSIP
- 92189F692
- Issuer
- VanEck
- Inception Date
- Dec 20, 2011
- Region
- Global (Broad)
- Category
- Health & Biotech Equities
- Leveraged
- 1x (No leverage)
- Index Tracked
- MVIS US Listed Pharmaceutical 25 Index
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Multi-Cap
- Asset Class Style
- Blend
- Assets Under Management
- $866M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PPH Performance Chart
VanEck Pharmaceutical ETF (PPH) is up 1.1% since the beginning of the year. PPH is currently trading at $103 per share. Investors who bought $1,000 worth of PPH shares 5 years ago would now be looking at an investment worth $1,573.
Loading charts...
Returns By Period
VanEck Pharmaceutical ETF (PPH) has returned 1.11% so far this year and 21.33% over the past 12 months. Over the last ten years, PPH has returned 8.33% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
VanEck Pharmaceutical ETF
- 1D
- 0.92%
- 1M
- -1.45%
- YTD
- 1.11%
- 6M
- 1.61%
- 1Y
- 21.33%
- 3Y*
- 11.87%
- 5Y*
- 9.48%
- 10Y*
- 8.33%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
PPH Monthly Returns History
Based on dividend-adjusted daily data since Feb 1, 2000, PPH's average daily return is +0.03%, while the average monthly return is +0.54%. At this rate, an investment would double in approximately 10.7 years.
Historically, 60% of months were positive and 40% were negative. The best month was Apr 2020 with a return of +12.0%, while the worst month was Feb 2009 at -12.4%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 7 months.
On a daily basis, PPH closed higher 51% of trading days. The best single day was Oct 13, 2008 with a return of +10.2%, while the worst single day was Mar 16, 2020 at -9.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.53% | 4.58% | -7.00% | -1.15% | 2.84% | -1.21% | 1.11% | ||||||
| 2025 | 3.06% | 5.32% | -2.69% | -1.26% | -1.64% | -0.03% | -5.06% | 7.17% | 1.67% | 2.86% | 10.77% | 0.94% | 22.00% |
| 2024 | 4.83% | 4.10% | 2.14% | -2.89% | 3.31% | 1.13% | 2.15% | 6.82% | -4.43% | -3.50% | -1.28% | -3.83% | 8.05% |
| 2023 | 0.77% | -3.43% | 2.62% | 2.47% | -4.08% | 4.12% | 2.60% | 1.84% | -2.49% | -5.29% | 4.25% | 4.03% | 6.95% |
| 2022 | -1.44% | -0.18% | 5.35% | -2.23% | 2.17% | -3.02% | 0.40% | -8.01% | -4.95% | 8.78% | 5.74% | 1.23% | 2.64% |
| 2021 | 2.51% | -0.90% | 2.21% | 1.24% | 3.78% | 1.26% | 2.87% | 1.58% | -4.23% | 3.69% | -4.95% | 8.12% | 17.79% |
Benchmark Metrics
VanEck Pharmaceutical ETF has an annualized alpha of 1.72%, beta of 0.65, and R2 of 0.47 versus S&P 500 Index. Calculated based on daily prices since February 01, 2000.
- This ETF participated in 70.44% of S&P 500 Index downside but only 66.36% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.65 may look defensive, but with R2 of 0.47 this ETF is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this ETF's risk.
- R2 of 0.47 means the benchmark explains less than half of this ETF's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 1.72%
- Beta
- 0.65
- R²
- 0.47
- Upside Capture
- 66.36%
- Downside Capture
- 70.44%
Expense Ratio
PPH has an expense ratio of 0.36%, placing it in the medium range.
Return for Risk
Risk / Return Rank
PPH ranks 36 for risk / return — below 36% of ETFs on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for VanEck Pharmaceutical ETF (PPH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PPH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.81 | ||
| Sortino ratioReturn per unit of downside risk | -0.84 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.37 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 1.99 | 2.78 | -0.79 |
| Martin ratioReturn relative to average drawdown | 4.86 | 12.44 | -7.58 |
Dividends
Dividend History
VanEck Pharmaceutical ETF provided a 2.08% dividend yield over the last twelve months, with an annual payout of $2.15 per share. The fund has been increasing its distributions for 3 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.15 | $1.84 | $1.71 | $1.70 | $1.20 | $1.25 | $1.11 | $1.14 | $1.08 | $1.14 | $1.27 | $1.26 |
Dividend yield | 2.08% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Monthly Dividends
The table displays the monthly dividend distributions for VanEck Pharmaceutical ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.84 | $0.00 | $0.00 | $0.84 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.61 | $0.00 | $0.00 | $0.39 | $0.00 | $0.31 | $1.84 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.41 | $0.00 | $0.41 | $1.71 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.66 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.34 | $0.00 | $0.31 | $1.70 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.27 | $0.00 | $0.24 | $1.20 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.35 | $0.00 | $0.27 | $1.25 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the VanEck Pharmaceutical ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the VanEck Pharmaceutical ETF was 51.45%, occurring on Mar 3, 2009. Recovery took 917 trading sessions.
The current VanEck Pharmaceutical ETF drawdown is 6.61%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Financial crisis2007–2009 | -51.45%Mar 2009 | 8y 2mo | 3y 7mo | 11y 9moDec 2000 - Oct 2012 |
COVID crash2020 | -30.19%Mar 2020 | 4y 7mo | 9mo 19d | 5y 5moAug 2015 - Jan 2021 |
Dot-com crash2000–2002 | -21.59%Mar 2000 | 27d | 28d | 1mo 25dFeb 2000 - Apr 2000 |
Bear market2022 | -20.26%Sep 2022 | 5mo 19d | 10mo 15d | 1y 3moApr 2022 - Aug 2023 |
2025 selloff2025 | -18.06%Apr 2025 | 7mo 9d | 7mo 5d | 1y 2moSep 2024 - Nov 2025 |
Drawdown Indicators
| PPH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.45% | -56.78% | +5.33% |
Max Drawdown (1Y)Largest decline over 1 year | -10.76% | -9.10% | -1.66% |
Max Drawdown (3Y)Largest decline over 3 years | -18.06% | -18.90% | +0.84% |
Max Drawdown (5Y)Largest decline over 5 years | -20.26% | -25.43% | +5.17% |
Max Drawdown (10Y)Largest decline over 10 years | -29.70% | -33.92% | +4.22% |
Current DrawdownCurrent decline from peak | -6.61% | -1.80% | -4.81% |
Average DrawdownAverage peak-to-trough decline | -17.29% | -10.71% | -6.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.40% | 2.03% | +2.37% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with PPH
Add VanEck Pharmaceutical ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PPH